Getagraph.com logo
S&P 500 Futures
(0.12%) 5 213.00 points
Dow Jones Futures
(0.12%) 39 042 points
Nasdaq Futures
(-0.03%) 18 190 points
Oil
(-0.85%) $77.81
Gas
(-1.23%) $2.17
Gold
(-0.20%) $2 326.60
Silver
(0.23%) $27.68
Platinum
(2.08%) $984.95
USD/EUR
(-0.03%) $0.928
USD/NOK
(0.31%) $10.86
USD/GBP
(0.07%) $0.797
USD/RUB
(-1.12%) $90.33

Actualizaciones en tiempo real para Sosei Group Corporation [4565.T]

Bolsa: JPX Sector: Healthcare Industria: Biotechnology
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-05-08)

Expected move: +/- 0.00%

Última actualización7 may 2024 @ 02:15
25% discount on Stockinvest.us - Use code: Podcast

0.33% ¥ 1 524.00

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 02:15):

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis...

Stats
Volumen de hoy 913 100
Volumen promedio 1.36M
Capitalización de mercado 136.32B
EPS ¥-2.13 ( 2024-02-13 )
Próxima fecha de ganancias ( ¥35.75 ) 2024-05-08
Last Dividend ¥2.50 ( 2015-03-27 )
Next Dividend ¥0 ( N/A )
P/E -17.48
ATR14 ¥0.889 (0.06%)

Volumen Correlación

Largo: 0.12 (neutral)
Corto: 0.36 (neutral)
Signal:(53.514) Neutral

Sosei Group Corporation Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sosei Group Corporation Correlación - Moneda/Commodity

The country flag -0.08
( neutral )
The country flag -0.06
( neutral )
The country flag 0.10
( neutral )
The country flag -0.13
( neutral )
The country flag 0.69
( moderate )
The country flag -0.13
( neutral )

Sosei Group Corporation Finanzas

Annual 2023
Ingresos: ¥12.77B
Beneficio Bruto: ¥7.87B (61.62 %)
EPS: ¥-87.17
FY 2023
Ingresos: ¥12.77B
Beneficio Bruto: ¥7.87B (61.62 %)
EPS: ¥-87.17
FY 2022
Ingresos: ¥15.57B
Beneficio Bruto: ¥14.64B (94.05 %)
EPS: ¥4.67
FY 2021
Ingresos: ¥17.71B
Beneficio Bruto: ¥16.78B (94.73 %)
EPS: ¥12.53

Financial Reports:

No articles found.

Sosei Group Corporation Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A)

Sosei Group Corporation Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend ¥2.50 2015-03-27
Last Dividend ¥2.50 2015-03-27
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out ¥2.50 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-05-07)
¥0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
7949.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7182.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
6420.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
5401.T Ex Dividend Knight 2023-09-28 Annually 0 0.00%
4410.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
3593.T Ex Dividend Knight 2023-09-28 Quarterly 0 0.00%
2811.T Ex Dividend Junior 2023-12-28 Annually 0 0.00%
1429.T Ex Dividend Knight 2023-12-28 Annually 0 0.00%
9729.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
8769.T Ex Dividend Knight 2024-03-28 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.5631.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.04581.200-1.525-1.830[0 - 0.3]
returnOnEquityTTM-0.1171.500-2.41-3.62[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.790.80010.008.00[1 - 3]
quickRatioTTM3.570.80010.008.00[0.8 - 2.5]
cashRatioTTM2.861.50010.0010.00[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM-3.341.000-2.35-2.35[3 - 30]
operatingCashFlowPerShareTTM-58.952.00-10.00-10.00[0 - 30]
freeCashFlowPerShareTTM-68.472.00-10.00-10.00[0 - 20]
debtEquityRatioTTM1.048-1.5005.81-8.71[0 - 2.5]
grossProfitMarginTTM0.6971.0001.7231.723[0.2 - 0.8]
operatingProfitMarginTTM-0.6921.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.07531.000-1.530-1.530[0.2 - 2]
assetTurnoverTTM0.08120.800-2.79-2.23[0.5 - 2]
Total Score-1.525

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-18.891.000-2.010[1 - 100]
returnOnEquityTTM-0.1172.50-1.551-3.62[0.1 - 1.5]
freeCashFlowPerShareTTM-68.472.00-10.00-10.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-58.952.00-10.00-10.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.3011.500-1.3260[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.4131.000-10.000[0.1 - 0.5]
Total Score-3.79

Sosei Group Corporation

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico